Related references
Note: Only part of the references are listed.Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
Christine Haider et al.
HEPATOLOGY (2019)
Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
Zujun Que et al.
CANCER CELL INTERNATIONAL (2019)
PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination
Yang Peng et al.
CANCER LETTERS (2019)
CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer
Chun Chen et al.
CELL DEATH & DISEASE (2019)
Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis
Xueqian Zhuang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Xiangyu Zhang
CANCER COMMUNICATIONS (2019)
CXCL5 as Regulator of Neutrophil Function in Cutaneous Melanoma
Agnes L. Forsthuber et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5
Sandy Giuliano et al.
THERANOSTICS (2019)
Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone
Hernan Roca et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway
Dong Cui et al.
BIOCHIMIE (2018)
Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis
Binwu Hu et al.
CANCER CELL INTERNATIONAL (2018)
CXCL5 Facilitates Melanoma Cell-Neutrophil Interaction and Lymph Node Metastasis
Ana Soler-Cardona et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells
Lin Wang et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2018)
The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer
Su Jin Lee et al.
TRANSLATIONAL ONCOLOGY (2018)
CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells
Xiaona Feng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment
Gurkan Mollaoglu et al.
IMMUNITY (2018)
A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma
Baojia Zou et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
Yana G. Najjar et al.
CLINICAL CANCER RESEARCH (2017)
TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils
P. F. Yu et al.
ONCOGENE (2017)
Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways
Jingkun Zhao et al.
MOLECULAR CANCER (2017)
A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
Z. Xiang et al.
ONCOGENE (2017)
CXCL5 Plays a Promoting Role in Osteosarcoma Cell Migration and Invasion in Autocrine- and Paracrine-Dependent Manners
Hongsheng Dang et al.
ONCOLOGY RESEARCH (2017)
The clinical significance of CXCL5 in non-small cell lung cancer
Kongju Wu et al.
ONCOTARGETS AND THERAPY (2017)
Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression
Wen Wen Xu et al.
NATURE COMMUNICATIONS (2017)
Role of CXC group chemokines in lung cancer development and progression
Artjoms Spaks
JOURNAL OF THORACIC DISEASE (2017)
Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer
Anne F. Schott et al.
CLINICAL CANCER RESEARCH (2017)
CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients
Xi Zhu et al.
TUMOR BIOLOGY (2016)
Immunohistochemical distinction of metastases of renal cell carcinoma with molecular analysis of overexpression of the chemokines CXCR2 and CXCR3 as independent positive prognostic factors for the tumorigenesis
Bijan Rezakhaniha et al.
IUBMB LIFE (2016)
被撤回的出版物: CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners (Retracted article. See vol. 46, 2021)
Zhijie Dai et al.
ONCOLOGY REPORTS (2016)
Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling
Zhenfeng Guan et al.
SCIENTIFIC REPORTS (2016)
The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
Zhenglin Wang et al.
BMC CANCER (2015)
CXCR2/CXCL5 axis contributes to epithelial mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling
Shao-Lai Zhou et al.
CANCER LETTERS (2015)
Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer
Jong-Baeck Lim et al.
CYTOKINE (2015)
CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma
Huimin An et al.
EUROPEAN JOURNAL OF CANCER (2015)
CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9
Ye Gao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
Li Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Microenvironmental regulation of therapeutic response in cancer
Florian Klemm et al.
TRENDS IN CELL BIOLOGY (2015)
CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer
Tomohiko Nishi et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma
Anastasios Stofas et al.
BMC CANCER (2014)
IL-17A Produced by γδ T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
Shoubao Ma et al.
CANCER RESEARCH (2014)
CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils
Shao-Lai Zhou et al.
CARCINOGENESIS (2014)
Prediction of Survival in Resected Non-Small Cell Lung Cancer Using a Protein Expression-Based Risk Model: Implications for Personalized Chemoprevention and Therapy
Kathryn A. Gold et al.
CLINICAL CANCER RESEARCH (2014)
Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression
Po-Lin Kuo et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma
Ping Sui et al.
MEDICAL ONCOLOGY (2014)
Overexpression of interleukin-8 receptor 2 (IL-8R2) indicates better prognosis in esophageal adenocarcinoma and squamous cell carcinoma procession
Bing Liang et al.
MEDICAL ONCOLOGY (2014)
Platelets guide the formation of early metastatic niches
Myriam Labelle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Steven L. Highfill et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes
Oksana Kowalczuk et al.
TUMOR BIOLOGY (2014)
Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
Esak Lee et al.
NATURE COMMUNICATIONS (2014)
CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
Pierre Saintigny et al.
CANCER RESEARCH (2013)
Tumor associated macrophages and neutrophils in cancer
Maria Rosaria Galdiero et al.
IMMUNOBIOLOGY (2013)
CXCL5 limits macrophage foam cell formation in atherosclerosis
Anthony Rousselle et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/Snail signaling pathway
Y-L Hsu et al.
ONCOGENE (2013)
A Novel Statistical Prognostic Score Model that Includes Serum CXCL5 Levels and Clinical Classification Predicts Risk of Disease Progression and Survival of Nasopharyngeal Carcinoma Patients
Haibo Zhang et al.
PLOS ONE (2013)
Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice
Ana M. Gil-Bernabe et al.
BLOOD (2012)
CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer
Mikio Kawamura et al.
EUROPEAN JOURNAL OF CANCER (2012)
Overexpression of CXCL5 Mediates Neutrophil Infiltration and Indicates Poor Prognosis for Hepatocellular Carcinoma
Shao-Lai Zhou et al.
HEPATOLOGY (2012)
Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts
Hirohisa Okabe et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models
Yan Ning et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Expression of Interleukin-8 Receptor CXCR2 and Suppressor of Cytokine Signaling-3 in Astrocytic Tumors
Penelope Korkolopoulou et al.
MOLECULAR MEDICINE (2012)
High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma
Liang Han et al.
MEDICAL ONCOLOGY (2012)
Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic Cancer
Aihua Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
Hideaki Ijichi et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
TGF-β Receptor II Loss Promotes Mammary Carcinoma Progression by Th17-Dependent Mechanisms
Sergey V. Novitskiy et al.
CANCER DISCOVERY (2011)
Identification and validation of genes involved in gastric tumorigenesis
Thangarajan Rajkumar et al.
CANCER CELL INTERNATIONAL (2010)
CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis
Gong Yang et al.
CLINICAL CANCER RESEARCH (2010)
Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression
Yong Park et al.
MEDICAL ONCOLOGY (2010)
Snail Promotes CXCR2 Ligand-Dependent Tumor Progression in Non-Small Cell Lung Carcinoma
Jane Yanagawa et al.
CLINICAL CANCER RESEARCH (2009)
ELR plus CXC chemokine expression in benign and malignant colorectal conditions
Claudia Rubie et al.
BMC CANCER (2008)
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis
Li Yang et al.
CANCER CELL (2008)
Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients
Frank M. Speetjens et al.
CLINICAL CANCER RESEARCH (2008)
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
Ivan Bieche et al.
ENDOCRINE-RELATED CANCER (2007)
CXCL5 overexpression is associated with late stage gastric cancer
Jeong Youp Park et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
A novel inflammatory pathway recruitment: Role for the kinin chemokine CXCL5
Johan Duchene et al.
JOURNAL OF IMMUNOLOGY (2007)
Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling
Y. F. Wong et al.
ONCOGENE (2007)
Down-regulation of CXCL5 inhibits squamous carcinogenesis
H Miyazaki et al.
CANCER RESEARCH (2006)
Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis
H Miyazaki et al.
ORAL ONCOLOGY (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer
M Pold et al.
CANCER RESEARCH (2004)
Expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils
T Persson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Share Paper
